AMACR and prostate cancer: Along this line, we speculated that the AMACR-induced cell cycle progression might be operated by more diverse mechanisms, perhaps indirect and cell type-dependent, given the previously reported G2/M cell cycle arrest in AMACR-silenced LAPC-4 prostatic cancer cells [26].